Watertime, Author at PsyNews.com

Home Authors Posts by Watertime

429 POSTS 0 COMMENTS

Cautious Optimism, Lingering Questions: Researchers React to Compass’ Phase 3 Psilocybin...

Compass Pathways’ Psilocybin Clears First Phase 3 Hurdle

PS 25 Morning Show – Day Three

When it Comes to Psychedelic Access, It’s the Messenger, Not the...

Australia’s Largest Private Health Insurer Commits $10M to Fund MDMA Therapy...

Ibogaine and the Future of Healing: Trevor Millar & Jonathan Dickinson...

Accredited Entheogenic Seminary: Inside the Congregation for Sacred Practices with Paul...

Does Cannabis Research Deserve As Much Funding As Ibogaine Research?

1...212223...43 Page 22 of 43

EDITOR PICKS

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on...

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research,...

Gov. Spencer Cox Signs Utah’s H.B. 390 Into Law, Authorizing Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime